Corcept Therapeutics Incorporated

Symbol: 0I3Q.L

LSE

33.3872

USD

Market price today

  • 29.0815

    P/E Ratio

  • 2.3875

    PEG Ratio

  • 3.48B

    MRK Cap

  • 0.00%

    DIV Yield

Corcept Therapeutics Incorporated (0I3Q-L) Stock Split, History Data

Working capital analysis

In terms of working capital, Corcept Therapeutics Incorporated maintains a healthy position. The total current assets of the company are valued at $458636000. This represents a growth rate of -8.035% compared to the previous year. Breaking down the current assets, the cash and investments are worth $135551000, exhibiting a growth rate of -68.954% year-on-year. The receivables, another significant portion of the current assets, are valued at $56823000. The year-on-year growth rate for receivables is 26.114%. The inventory, which forms a critical part of the assets, is valued at $7730000. This represents a healthy year-on-year growth of -54.612% On the liabilities side, the company's current liabilities total $104505000. This reflects a growth rate of 28.089% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
135.55
436.62
335.81
476.89
315.31
206.76
Receavebles
56.82
45.06
27.63
26.20
19.93
17.59
Inventory
7.73
17.03
17.95
21.16
17.41
16.24
Other
25.86
16.42
10.31
6.70
6.04
7.74
Total Current Assets
458.64
498.71
381.39
524.25
352.65
240.59
Acc Payable
17.40
11.98
6.91
10.55
7.54
8.27
Short Term Debt
0.15
1.14
0.53
2.05
3.46
0.00
Other Current Liab
85.14
68.47
0.53
2.05
30.13
27.55
Current Liabilities
104.50
81.59
6.91
10.55
41.13
35.81

Capital Structure

When examining the capital structure of Corcept Therapeutics Incorporated, it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $655935000. When juxtaposed with the previous year, this marks a growth rate of 6.164%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $108071000. Compared to the prior year, this reflects a growth rate of 22.441%. On the asset side, the cash and equivalent reserves are worth $149750000. The year-on-year growth of these reserves is -50.074%. The company's common stock, another important asset, holds a value of $133000, growing at a rate of 1.527% from the previous year. Finally, the company's retained earnings stand at $430288000, marking a growth rate of 37.796% year-over-year. These earnings represent the profits that Corcept Therapeutics Incorporated has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$655.93

Total liabilities

$108,071,000.00

Long term debt

$0.00

Cash and eqv

$149,750,000.00

Goodwill

$0.00

Retained earnings

$430,288,000.00

Common stock

$0.10

Enterprise Value

$29.13

Historical dividend key summary

Corcept Therapeutics Incorporated's dividend per share is $0.285, showing the earnings shared with shareholders per share. It has grown by -100.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.

YearsQ1Q2Q3Q4Total
20220.2850.0000.0000.0000.285

Net earnings per share (EPS)

Corcept Therapeutics Incorporated has an EPS of $0.27, which signifies the profit allocated per share of common stock. With a growth rate of -73.786% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
20240.27---0.27
20230.150.270.310.31.03
20220.20.240.30.150.89
20210.20.230.260.280.97
20200.260.250.190.220.92
20190.160.180.230.260.83
20180.150.160.150.190.65
20170.040.110.120.861.13
2016-0.00020.010.020.04070.07
2015-0.0474-0.0179-0.00550.0087-0.07
2014-0.14-0.0748-0.0594-0.0382-0.31
2013-0.12-0.12-0.11-0.11-0.46
2012-0.13-0.0857-0.0837-0.11-0.41
2011-0.0879-0.11-0.0764-0.12-0.40
2010-0.0969-0.0861-0.0986-0.0878-0.38
2009-0.11-0.098-0.0938-0.0825-0.38
2008-0.0977-0.0907-0.11-0.12-0.42
2007-0.0978-0.0408-0.0936-0.1-0.33
2006-0.3-0.35-0.28-0.15-1.08
2005-0.24-0.18-0.23-0.23-0.88
2004-0.29-0.18-0.18-0.24-0.89
2003-0.36-0.37-0.2-0.24-1.17

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 1.213.

What is company revenue per share?

The company revenue per share is 0.233.

What are firm earnings per share?

The firm earnings per share is 0.830.

What is Corcept Therapeutics Incorporated (0I3Q.L) ROIC (return on capital)?

Corcept Therapeutics Incorporated (0I3Q.L) ROIC (return on capital) is 0.218.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Corcept Therapeutics Incorporated (0I3Q.L) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 29.133

What is company debt to equity ratio?

The debt to equity ratio is 0.000

What are debt ratio numbers?

The debt ratio is 0.000

What is company price to sales ratio?

The price to sales ratio is 6.593